Cover Image
市場調查報告書

全球研究用抗體市場

Global Markets for Research Antibodies

出版商 BCC Research 商品編碼 323442
出版日期 內容資訊 英文 136 Pages
訂單完成後即時交付
價格
Back to Top
全球研究用抗體市場 Global Markets for Research Antibodies
出版日期: 2015年01月28日 內容資訊: 英文 136 Pages
簡介

全球研究用抗體市場2013年達到20億美元,2014年約達22億美元的規模。預計從2014年到2019年以6.2%的年複合成長率發展,2019年成長近30億美元的規模。

本報告提供全球研究用抗體市場現況與展望的相關調查,市場概要,市場趨勢,各地區、產品類型、研究用途、物種、主要研究領域的區分,終端用戶類型、購買要素、市場新趨勢、潛在的成長領域相關詳細分析,以及主要企業的簡介等彙整。

第1章 簡介

第2章 市場摘要

第3章 研究用抗體市場概要

  • 簡介
  • 歷史、現狀
  • 抗體技術概要

第4章 抗體的研究用途

  • 簡介
  • ELISA法/ELISPOT法
  • 西方墨點法
  • 免疫組織化學
  • 流式細胞技術(細胞分選)
  • 免疫細胞化學/免疫螢光染色法
  • 染色質免疫沉澱
  • 其他抗體用途

第5章 研究用抗體市場區分與預測

  • 研究用抗體市場概要
  • 研究用抗體的種類
  • 主要企業
  • 市場區隔:各地區
  • 區分:各產品類型
  • 區分:活性物種
  • 區分:宿主物種
  • 區分:克隆性種類
  • 區分:複合體
  • 區分:研究領域
  • 區分:用途
  • 區分:用戶類型
  • 目前研究用抗體市場上的陷阱
  • 市場預測

第6章 研究用抗體的用途為基礎的市場

  • 市場概要

第7章 流式細胞技術分析市場

  • 市場概要
  • 流式細胞儀分析的趨勢
  • 流式細胞技術設備市場
  • 流式細胞儀試劑、消耗品市場
  • 產品類型
  • 主要企業、成長策略
  • 市場佔有率與預測

第8章 自訂抗體服務市場

  • 市場概要
  • 服務類型
  • 主要企業
  • 市場佔有率與預測

第9章 市場趨勢、分析

  • 購買要素
  • 第三方品質評估系統
  • 研究津貼
  • JOURNAL CITATION
  • 抗體製造、用途的技術趨勢
  • 研究用抗體產業相關的M&A活動

第10章 市場成長的促進要素、抑制因素

  • 促進要素
  • 抑制因素

第11章 企業簡介

  • ABCAM
  • ABD SEROTEC (BIO-RAD)
  • ABNOVA
  • ACTIVE MOTIF
  • BD BIOSCIENCES
  • BECKMAN COULTER INC.
  • BETHYL LABORATORIES INC.
  • BIOLEGEND
  • BIO-TECHNE
  • CELL SIGNALING TECHNOLOGY
  • DAKO (AGILENT TECHNOLOGIES)
  • EBIOSCIENCE INC. (A SUBSIDIARY OF AFFYMETRIX)
  • EMD MILLIPORE
  • EVEREST BIOTECH LTD.
  • JACKSON IMMUNORESEARCH LABORATORIES INC.
  • LIFESPAN BIOSCIENCES INC.
  • MILTENYI BIOTEC GMBH
  • MORPHOSYS AG
  • ORIGENE TECHNOLOGIES
  • PROTEINTECH GROUP INC.
  • ROCKLAND IMMUNOCHEMICALS INC.
  • SANTA CRUZ BIOTECHNOLOGY INC.
  • SIGMA-ALDRICH CORP.
  • THERMO FISHER SCIENTIFIC INC.
  • UNITED STATES BIOLOGICAL

圖表

目錄
Product Code: BIO141A

REPORT HIGHLIGHTS

The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019.

This report provides:

  • An overview of the global market for antibodies used in research.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Segmentation of the market by geography, product types, research applications, species, and major research area.
  • Details concerning end user types, purchasing factors, new market trends, and potential growth opportunities that are available.
  • Discussion on the factors affecting strategies of antibody companies, the effect of research funding, and third-party quality evaluation systems.
  • Analysis of the competitive landscape and key competitor market shares.

SCOPE OF REPORT

This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.

ANALYST'S CREDENTIALS

Mike Fan has more than 20 years of experience in biotech research and development (R&D) and life science marketing in academia and industry. Dr. Fan has a broad range of experience in chemical, biochemical and biomedical areas, including biochemical engineering (e.g., microbial fermentation, biocatalysis, metabolic engineering), chemical synthesis, biomedical engineering (e.g., biomedical instrument development, microarray technologies), molecular genetics, genetic analysis, drug discovery, cancer biology, cancer immunology, targeted therapy and stem cell research. He holds a PhD in Chemical Engineering and an MBA with a focus on marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • INTENDED AUDIENCE
  • SCOPE OF REPORT
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - MARKET SUMMARY

  • KEY DRIVERS FOR MARKET GROWTH
  • SUMMARY TABLE: GLOBAL RESEARCH ANTIBODY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL RESEARCH ANTIBODY MARKET BY REGION, 2013-2019 ($ MILLIONS)

CHAPTER 3 - OVERVIEW OF THE RESEARCH ANTIBODY MARKET

  • INTRODUCTION
  • HISTORY AND CURRENT STATE
    • BACKGROUND OF THE ANTIBODY AND ITS PRODUCTION
      • Discovery and Usage of Antibody Responses
      • Structure of an Antibody (Immunoglobulin) Molecule
      • Antibody Classes and Subclasses
      • Polyclonal and Monoclonal Antibodies
      • Purification, Characterization and Modification of Antibodies
    • CURRENT STATUS AND ISSUES
  • OVERVIEW OF ANTIBODY TECHNOLOGY
    • TRADITIONAL ANTIBODY TECHNOLOGIES
      • Polyclonal Antibody Technology
      • Monoclonal Antibody Technology
        • Hybridoma Technology
        • Recombinant Antibody Technology
        • Antibody Phage Display Technology
    • EMERGING ANTIBODY TECHNOLOGIES
      • Hybridoma Free Technology
      • Oligoclonal Antibodies
      • Genomic Antibody Technology
      • Single-Chain Fragment Variable
      • Single-Domain Antibody (Nanobody, VHH)
      • Antibody Mimetics

CHAPTER 4 - RESEARCH APPLICATIONS OF ANTIBODIES

  • INTRODUCTION
  • ELISA/ELISPOT
    • DIRECT ELISA
    • INDIRECT ELISA
    • COMPETITIVE ELISA
    • SANDWICH ELISA
    • ELISPOT ASSAYS
    • FLUOROSPOT ASSAY
    • EMERGING TECHNOLOGIES OR PLATFORMS IN ELISA ASSAYS
  • WESTERN BLOT
    • 1-D GEL ELECTROPHORESIS
    • 2-D GEL ELECTROPHORESIS
    • EMERGING TECHNOLOGIES/PLATFORMS IN WESTERN BLOT
      • Zestern Analysis
      • Western Blot Automation
  • IMMUNOHISTOCHEMISTRY
  • FLOW CYTOMETRY (INCLUDING CELL SORTING)
    • EMERGING TECHNOLOGIES OR PLATFORMS IN FLOW CYTOMETRY
  • IMMUNOCYTOCHEMISTRY/IMMUNOFLUORESCENT STAINING
  • CHROMATIN IMMUNOPRECIPITATION
  • OTHER APPLICATIONS OF ANTIBODIES
    • ANTIBODY ARRAYS

CHAPTER 5 - SEGMENTATION OF AND FORECAST FOR THE RESEARCH ANTIBODY MARKET

  • RESEARCH ANTIBODY MARKET OVERVIEW
  • TYPES OF RESEARCH ANTIBODIES
  • MAJOR PLAYERS
    • TABLE 1 DISTRIBUTION OF ANTIBODY SUPPLIERS BY REGION, AS OF OCTOBER 2014 (%)
    • TABLE 2 DISTRIBUTION OF ANTIBODY SUPPLIERS BY STATE IN THE U.S., AS OF OCTOBER 2014 (%)
  • MARKET SEGMENTS BY REGION
    • TABLE 3 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 1 GLOBAL RESEARCH ANTIBODY MARKET SHARES BY REGION, 2013-2019 ($ MILLIONS)
    • FIGURE 2 GLOBAL RESEARCH ANTIBODY MARKET SHARES BY REGION, 2013 (%)
    • FIGURE 3 GLOBAL RESEARCH ANTIBODY MARKET SHARE BY REGION, 2019 (%)
  • SEGMENTS BY PRODUCT TYPE
    • TABLE 4 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 4 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • TABLE 5 U.S. MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 5 U.S. MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • TABLE 6 EUROPE MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 6 EUROPE MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • TABLE 7 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 7 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • TABLE 8 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 8 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
  • SEGMENTS BY REACTIVE SPECIES
    • TABLE 9 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 9 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • TABLE 10 U.S. MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 10 U.S. MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • TABLE 11 EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 11 EUROPE MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • TABLE 12 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 12 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • TABLE 13 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 13 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
  • SEGMENTS BY HOST SPECIES
    • TABLE 14 GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 14 GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 15 GLOBAL MARKET SHARE FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2019 (%)
    • TABLE 15 U.S. MARKETS FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 16 U.S. MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • TABLE 16 EUROPEAN MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 17 EUROPEAN MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • TABLE 17 ASIA-PACIFIC MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 18 ASIA-PACIFIC MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • TABLE 18 REST OF WORLD MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • FIGURE 19 REST OF WORLD MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
  • SEGMENTS BY CLONALITY TYPE
    • TABLE 19 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • FIGURE 20 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • TABLE 20 U.S. MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • FIGURE 21 U.S. MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • TABLE 21 EUROPE MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • FIGURE 22 EUROPE MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • TABLE 22 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • FIGURE 23 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • TABLE 23 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • FIGURE 24 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
  • SEGMENTS BY CONJUGATE
    • TABLE 24 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • FIGURE 25 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • TABLE 25 U.S. MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • FIGURE 26 U.S. MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • TABLE 26 EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • FIGURE 27 EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • TABLE 27 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • FIGURE 28 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • TABLE 28 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • FIGURE 29 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
  • SEGMENTS BY RESEARCH AREA
    • TABLE 29 U.S. RESEARCH ANTIBODY MARKET BY MAJOR RESEARCH AREA, THROUGH 2019 ($ MILLIONS)
  • SEGMENTS BY APPLICATION
    • TABLE 30 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 30 GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY APPLICATION, 2013 (%)
    • FIGURE 31 GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY APPLICATION, 2019 (%)
    • TABLE 31 U.S. MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 32 EUROPE MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 33 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 34 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • SEGMENTS BY USER TYPE
    • TABLE 35 GLOBAL MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 32 GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY END-USER TYPE, 2013 (%)
    • FIGURE 33 GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY END-USER TYPE, 2019 (%)
    • TABLE 36 U.S. MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 37 EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 38 ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
      • TABLE 39 REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
  • PITFALLS IN THE CURRENT RESEARCH ANTIBODY MARKET
    • NON-SPECIFICITY
    • NON-REPRODUCIBILITY
  • MARKET PROJECTIONS

CHAPTER 6 - APPLICATION-BASED MARKETS FOR RESEARCH ANTIBODIES

  • APPLICATION-BASED MARKET OVERVIEW
    • MARKET FOR WESTERN BLOT ANALYSIS
      • TABLE 40 MARKET FOR WESTERN BLOT ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • MARKET FOR ELISA
      • TABLE 41 MARKET FOR ELISA ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • MARKET FOR IMMUNOHISTOCHEMISTRY
      • TABLE 42 MARKET FOR IHC ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • MARKET FOR IMMUNOFLUORESCENT STAINING
      • TABLE 43 MARKET FOR ICC/IF ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)

CHAPTER 7 - MARKET FOR FLOW CYTOMETRY ANALYSIS

  • MARKET OVERVIEW
  • TRENDS IN FLOW CYTOMETRIC ANALYSIS
    • PORTABLE CYTOMETERS
    • MASS CYTOMETRY
  • MARKET FOR FLOW CYTOMETRY INSTRUMENTS
  • MARKET FOR FLOW CYTOMETRY REAGENTS AND CONSUMABLES
    • FLUORESCENT DYES
    • ANTIBODIES
    • BEADS
  • PRODUCT TYPES
  • MAJOR PLAYERS AND GROWTH STRATEGIES
  • MARKET SHARE AND PROJECTIONS
    • TABLE 44 MARKET FOR FLOW CYTOMETRY ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)

CHAPTER 8 - MARKET FOR CUSTOM ANTIBODY SERVICES

  • MARKET OVERVIEW
  • TYPES OF SERVICES
    • ANTIBODY CUSTOM MANUFACTURING
      • Polyclonal Antibodies
      • Monoclonal Antibodies
      • Antibody Fragmentation
      • Recombinant Antibodies
    • ANTIBODY CONJUGATION
    • ANTIGEN PREPARATION
  • MAJOR PLAYERS
    • TABLE 45 MAJOR SUPPLIERS FOR CUSTOM ANTIBODY SERVICES
    • TABLE 46 DISTRIBUTION OF SUPPLIERS FOR CUSTOM ANTIBODY SERVICES, BY REGION (%)
    • TABLE 47 DISTRIBUTION OF ANTIBODY SUPPLIERS BY STATE IN THE U.S. (AS OF NOVEMBER 2014) (%)
    • FIGURE 34 DISTRIBUTION OF SUPPLIERS FOR CUSTOM ANTIBODY SERVICES, BY COUNTRY (%)
  • MARKET SHARE AND PROJECTIONS
    • TABLE 48 MARKET FOR ANTIBODY CUSTOM SERVICES BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 35 MARKET SHARE OF ANTIBODY CUSTOM SERVICES BY REGION, 2013 (%)
    • FIGURE 36 MARKET SHARE OF ANTIBODY CUSTOM SERVICES BY REGION, 2019 (%)

CHAPTER 9 - MARKET TREND ANALYSIS

  • PURCHASING FACTORS
  • THIRD-PARTY QUALITY EVALUATION SYSTEMS
  • RESEARCH GRANTS
  • JOURNAL CITATIONS
    • TABLE 49 MOST CITED ANTIBODIES AND THEIR SUPPLIERS
  • TECHNOLOGICAL TRENDS IN ANTIBODY PRODUCTION AND APPLICATION
  • M&A ACTIVITIES RELATED TO THE RESEARCH ANTIBODY INDUSTRY
    • WUXI APP TEC ACQUIRES ABGENT
    • ABCAM ACQUIRES EPITOMICS
    • AGILENT ACQUIRES DAKO
    • AFFYMETRIX ACQUIRES EBIOSCIENCE
    • BIO-RAD ACQUIRES ABD SEROTEC
    • THERMO FISHER PIERCE ANTIBODIES MERGES WITH LIFE TECHNOLOGIES ANTIBODIES
    • FLUIDIGM ACQUIRES DVS SCIENCES
    • BIO-TECHNE (R&D SYSTEMS) ACQUIRES NOVUS BIOLOGICALS
    • BIO-TECHNE (R&D SYSTEMS) ACQUIRES PROTEINSIMPLE
    • BIOLEGEND ACQUIRES COVANCE ANTIBODY SERVICES
    • GERMAN MERCK ACQUIRES SIGMA

CHAPTER 10 - DRIVING FORCES AND LIMITING FACTORS OF MARKET GROWTH

  • DRIVING FORCES FOR MARKET GROWTH
    • NEW DISCOVERIES IN BIOLOGICAL SCIENCES
    • NEW ANTIBODY TECHNOLOGIES AND ANTIBODY TYPES
    • ANTIBODY-BASED DRUG DISCOVERY AND DEVELOPMENT
    • HOT RESEARCH AREAS
    • INCREASED GOVERNMENT FUNDING IN EMERGING MARKETS
    • NEED FOR FURTHER HUMAN GENOMIC AND PROTEOMIC RESEARCH
    • NEED FOR QUALITY ANTIBODIES IN THE CURRENT RESEARCH COMMUNITY
    • NEED FOR CUSTOM ANTIBODY SERVICES
    • NEW APPLICATION-FOCUSED TECHNOLOGY PLATFORMS
  • FACTORS LIMITING MARKET GROWTH
    • RESEARCH FUNDING
    • VALIDATION TECHNOLOGIES
    • SUPPLIERS
    • MARKET ACCEPTANCE OR BRAND TRUST

CHAPTER 11 - COMPANY PROFILES

  • ABCAM
  • ABD SEROTEC (BIO-RAD)
  • ABNOVA
  • ACTIVE MOTIF
  • BD BIOSCIENCES
  • BECKMAN COULTER INC.
  • BETHYL LABORATORIES INC.
  • BIOLEGEND
  • BIO-TECHNE
  • CELL SIGNALING TECHNOLOGY
  • DAKO (AGILENT TECHNOLOGIES)
    • DAKO NORTH AMERICA INC.
  • EBIOSCIENCE INC. (A SUBSIDIARY OF AFFYMETRIX)
  • EMD MILLIPORE
  • EVEREST BIOTECH LTD.
  • JACKSON IMMUNORESEARCH LABORATORIES INC.
  • LIFESPAN BIOSCIENCES INC.
  • MILTENYI BIOTEC GMBH
    • MILTENYI BIOTEC INC. (RESEARCH PRODUCTS)
  • MORPHOSYS AG
  • ORIGENE TECHNOLOGIES
  • PROTEINTECH GROUP INC.
  • ROCKLAND IMMUNOCHEMICALS INC.
  • SANTA CRUZ BIOTECHNOLOGY INC.
  • SIGMA-ALDRICH CORP.
  • THERMO FISHER SCIENTIFIC INC.
  • UNITED STATES BIOLOGICAL

LIST OF TABLES

  • SUMMARY TABLE GLOBAL RESEARCH ANTIBODY MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: DISTRIBUTION OF ANTIBODY SUPPLIERS BY REGION, AS OF OCTOBER 2014 (%)
    • TABLE 2: DISTRIBUTION OF ANTIBODY SUPPLIERS BY STATE IN THE U.S., AS OF OCTOBER 2014 (%)
    • TABLE 3: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 4: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 5: U.S. MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 6: EUROPE MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 7: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 8: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 9: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 10: U.S. MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 11: EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 12: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 13: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 15: U.S. MARKETS FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 16: EUROPEAN MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: ASIA-PACIFIC MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 18: REST OF WORLD MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019 ($ MILLIONS)
    • TABLE 19: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • TABLE 20: U.S. MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • TABLE 21: EUROPE MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • TABLE 22: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • TABLE 23: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • TABLE 25: U.S. MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • TABLE 26: EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • TABLE 27: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • TABLE 28: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019 ($ MILLIONS)
    • TABLE 29: U.S. RESEARCH ANTIBODY MARKET BY MAJOR RESEARCH AREA, THROUGH 2019 ($ MILLIONS)
    • TABLE 30: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 31: U.S. MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 32: EUROPE MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 33: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 34: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 35: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 36: U.S. MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 37: EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 38: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 39: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: MARKET FOR WESTERN BLOT ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 41: MARKET FOR ELISA ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 42: MARKET FOR IHC ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 43: MARKET FOR ICC/IF ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 44: MARKET FOR FLOW CYTOMETRY ANTIBODIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 45: MAJOR SUPPLIERS FOR CUSTOM ANTIBODY SERVICES
    • TABLE 46: DISTRIBUTION OF SUPPLIERS FOR CUSTOM ANTIBODY SERVICES, BY REGION (%)
    • TABLE 47: DISTRIBUTION OF ANTIBODY SUPPLIERS BY STATE IN THE U.S. (AS OF NOVEMBER 2014) (%)
    • TABLE 48: MARKET FOR ANTIBODY CUSTOM SERVICES BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 49: MOST CITED ANTIBODIES AND THEIR SUPPLIERS

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL RESEARCH ANTIBODY MARKET BY REGION, 2013-2019 ($ MILLIONS)
    • FIGURE 1: GLOBAL RESEARCH ANTIBODY MARKET SHARES BY REGION, 2013-2019 ($ MILLIONS)
    • FIGURE 2: GLOBAL RESEARCH ANTIBODY MARKET SHARES BY REGION, 2013 (%)
    • FIGURE 3: GLOBAL RESEARCH ANTIBODY MARKET SHARE BY REGION, 2019 (%)
    • FIGURE 4: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • FIGURE 5: U.S. MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • FIGURE 6: EUROPE MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • FIGURE 7: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • FIGURE 8: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019 ($ MILLIONS)
    • FIGURE 9: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 10: U.S. MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 11: EUROPE MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 12: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 13: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 14: GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 15: GLOBAL MARKET SHARE FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2019 (%)
    • FIGURE 16: U.S. MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 17: EUROPEAN MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 18: ASIA-PACIFIC MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 19: REST OF WORLD MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019 ($ MILLIONS)
    • FIGURE 20: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • FIGURE 21: U.S. MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • FIGURE 22: EUROPE MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • FIGURE 23: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • FIGURE 24: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019 ($ MILLIONS)
    • FIGURE 25: GLOBAL MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • FIGURE 26: U.S. MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • FIGURE 27: EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • FIGURE 28: ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • FIGURE 29: REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019 ($ MILLIONS)
    • FIGURE 30: GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY APPLICATION, 2013 (%)
    • FIGURE 31: GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY APPLICATION, 2019 (%)
    • FIGURE 32: GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY END-USER TYPE, 2013 (%)
    • FIGURE 33: GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY END-USER TYPE, 2019 (%)
    • FIGURE 34: DISTRIBUTION OF SUPPLIERS FOR CUSTOM ANTIBODY SERVICES, BY COUNTRY (%)
    • FIGURE 35: MARKET SHARE OF ANTIBODY CUSTOM SERVICES BY REGION, 2013 (%)
    • FIGURE 36: MARKET SHARE OF ANTIBODY CUSTOM SERVICES BY REGION, 2019 (%)
Back to Top